[1]. Changelian PS, et al. The specificity of JAK3 kinase inhibitors. Blood. 28 Feb 15;111(4):2155-7. Epub 27 Dec 19.
[2]. Zhang H, et al. WHI-P154 enhances the chemotherapeutic effect of anticancer agents in ABCG2-overexpressing cells. Cancer Sci. 214 Aug;15(8):171-8.
[3] Narla RK, et al. 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells. Clin Cancer Res, 1998, 4(6), 145-1414.